Standout Papers

Antisense Oligonucleotide... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
    2020 355 citations Karishma Dhuri, Elias Quijano et al. Journal of Clinical Medicine profile →

Immediate Impact

16 by Nobel laureates 1 from Science/Nature 84 hit
Sub-graph 1 of 22

Citing Papers

Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines
2025 Hit
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
2024 Hit

Works of Karishma Dhuri being referenced

Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy
2020

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Karishma Dhuri 481 135 74 38 38 10 579
Kathrin Löffler 535 1.1× 195 1.4× 83 1.1× 63 1.7× 47 1.2× 8 634
Frida Danielsson 361 0.8× 81 0.6× 49 0.7× 26 0.7× 74 1.9× 12 620
Jiyeon Lee 330 0.7× 86 0.6× 34 0.5× 39 1.0× 45 1.2× 14 668
Joshua D. Bryant 443 0.9× 109 0.8× 87 1.2× 48 1.3× 83 2.2× 10 608
Ella G. Frolova 461 1.0× 93 0.7× 60 0.8× 7 0.2× 42 1.1× 9 637
Chantal Beekman 470 1.0× 178 1.3× 38 0.5× 9 0.2× 78 2.1× 11 682
Susana Esteban-Rubio 405 0.8× 263 1.9× 28 0.4× 24 0.6× 52 1.4× 9 538
Ru‐Ting Huang 339 0.7× 146 1.1× 55 0.7× 41 1.1× 123 3.2× 16 588
Carol M. Julin 512 1.1× 53 0.4× 123 1.7× 19 0.5× 16 0.4× 13 636
Viola Borgdorff 454 0.9× 122 0.9× 36 0.5× 14 0.4× 55 1.4× 10 629

All Works

Loading papers...

Rankless by CCL
2026